New Haven

Gateway Community College in New Haven will unveil its new Leadership in Energy & Environmental Design building...

The state is investing up to $51 million as part of its “First Five” program for biopharmaceutical company Alexion Pharmaceuticals to move its corporate headquarters from Cheshire to New Haven, adding up to 300 jobs there over the next few years.

Southern Connecticut Bancorp Inc. barely escaped delisting from the New York Stock Exchange by reconstituting the New Haven lender's board of directors to satisfy exchange requirements, a regulatory filing shows.

Dennis Liotta, a board member at Achillion Pharmaceuticals Inc., this week placed a $123,900 investment bet on the future of the New Haven hepatitis C drug developer – and so far he's ahead, Forbes.com reports.

Connecticut put another $200,000 into a New Haven company devising a game system and other products to identify and treat children with learning-behavior disabilities, authorities say.

Connecticut Attorney General George Jepsen on Monday called for Berlin electric utility Connecticut Light & Power to...

New Haven drug developer Achillion Pharmaceuticals Inc. added biopharma veteran Kurt Graves to its board as an independent director.

New Haven hepatitis C drug developer Achillion Pharmaceuticals Inc. says Chief Medical Officer Elizabeth Olek is leaving the company, but did not say why, The Associated Press reports.

New Haven's Long Wharf Theatre is nearer to its Mainstage renovation after getting $4 million in loans from First Niagara Bank to match up with pledges and donations, authorities say.

The Connecticut Department of Energy & Environmental Protection will host a waste and recycling management summit at...